Navigation Links
EDARBYCLOR (azilsartan medoxomil and chlorthalidone) Now Available in U.S. Pharmacies for Patients with Hypertension
Date:2/6/2012

y blocking the action of angiotensin II, a vasopressor hormone, which naturally exists within the body. When EDARBI blocks the angiotensin II receptor, blood vessels can stay relaxed and open, and blood pressure can be reduced. EDARBI is indicated for the treatment of hypertension to lower blood pressure in adults, either alone or in combination with other antihypertensive agents. The recommended dose of EDARBI in adults is 80 mg taken once daily. A starting dose of 40 mg may be appropriate for patients on high doses of diuretics. EDARBI is approved in the United States, Europe and Mexico.

EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is a fixed-dose combination therapy for the treatment of hypertension that combines azilsartan medoxomil and chlorthalidone in a single tablet. Chlorthalidone reduces the amount of water in the body by increasing the flow of urine, which helps lower blood pressure. EDARBYCLOR is indicated for the treatment of hypertension to lower blood pressure; it may be used in patients not adequately controlled with monotherapy and as an initial therapy if a patient is likely to need multiple drugs to achieve blood pressure goals. The recommended starting dose of EDARBYCLOR in adults is 40/12.5 mg taken orally once daily. The maximal dose is 40/25 mg.

Important Safety Information
Boxed Warning for FETAL TOXICITY

When pregnancy is detected, patients should discontinue EDARBI or EDARBYCLOR as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.

EDARBYCLOR is contraindicated in patients with anuria.

Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. When pregnancy is detected, patients should discontinue EDARBI or EDARBYCLOR as soon as possible. Thiazides cross the placental
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
2. EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients With Hypertension
3. FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
4. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
5. New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
6. New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
7. NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription
8. PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States
9. Nearly 9 Million Kaiser Permanente Health Records Securely Available on Mobile Devices
10. Edgemont - New Fluoxetine Tablets, 60 mg Now Available
11. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013  Decision Resources, one of the ... pharmaceutical and healthcare issues, finds that the ... efficacy endpoints, including overall survival and time ... over surveyed U.S. and European oncologists, prescribing ... breast cancer. The two novel emerging therapies ...
(Date:5/21/2013)... SANTA CLARA, Calif. , May 21, ... a game-changing embedded-ultrasound platform, today announced the ... Toolkit that allows complete network-based communications with ... demonstrate its latest embedded-ultrasound technology, including this ... Sao Paulo, Brazil ...
(Date:5/21/2013)... , May 21, 2013  The North Shore-LIJ ... used to measure hand-washing compliance at North Shore University ... introducing cameras in operating rooms at Forest ... http://photos.prnewswire.com/prnh/20130521/NY17810 ) The new pilot program strengthens ... their operating rooms (ORs), the first time in the ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... Dec. 8, 2010 Boehringer Ingelheim Pharmaceuticals, Inc. ... clinical trial in the United States to investigate ... 2992), for the treatment of patients with advanced ... administered irreversible inhibitor of both the epidermal growth ...
... Dec. 8, 2010 Sutro Biopharma, a biopharmaceutical ... with improved pharmaceutical properties, today announced that it ... officer (CSO). Dr. Hallam will lead Sutro,s ongoing ... protein biochemical synthesis platform for the research and ...
Cached Medicine Technology:Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer 2Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer 3Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer 4Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer 2
(Date:5/22/2013)... Those who have already gone through a ... that the hardest work is yet to come. As of ... band patients have special health needs that should be addressed ... Post Lap-Band Surgery” abclocal.go.com/kabc/story?section=news/food_coach&id=9078455). Bariatric surgeon Dr. Madan offers four ... that weight can be lost and kept off. , First, ...
(Date:5/22/2013)... 2013 Athletic-Minded Traveler LLC, a ... released today its 2013 U.S. Business Hotel “Fit ... the company’s recommendation after ongoing research of over ... by the editorial staff. Selection criteria included ... court, etc.), in-room workout choices, healthy food offerings, ...
(Date:5/21/2013)... May 22, 2013 The University of ... up with HEALTHY DINING to help Coloradans make healthier ... The new program is called HEALTHY DINING IN COLORADO. ... are already participating in Colorado. Restaurants will offer a ... adults emphasizing lean protein, vegetables, fruits, whole grains and ...
(Date:5/21/2013)... Swimsuit season is almost here. The "Get Ready ... begun with a 35% discount. , Cellulite forms mainly in ... the dreaded cellulite even if they are in shape. ... have been stored as toxic lymph and smashed together, giving ... specific program that works to dissolve the toxins and fatty ...
(Date:5/21/2013)... Texas (PRWEB) May 22, 2013 Feed ... increasing meat production industry value chain. Most of the ... form of injectable, pellets, liquids, and powders. There are ... different quantities and concentrations depending upon the type of ... minerals, and vitamins that provide essential nutrition to the ...
Breaking Medicine News(10 mins):Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 2Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 3Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4
... from Cochrane Collaboration (International private organization which reports review ... from over 50 clinical trials involving influenza symptoms and ... the old drugs which were used against influenza were ... amantadine and rimantidine which were used to control symptoms ...
... Scotland are being encouraged to employ people with Asperger's ... with others. Scotland has a total of 50,000 people ... to them getting gainful employment. //People who suffer from ... interview. ,Even though the intelligence of ...
... from McMaster University has reported in the Journal Science ... that the scientists screened 480 strains of Streptomyces species ... the strains were multi-drug resistance //as they were tested ... ,The researchers were astonished by the ...
... transmission case is due today in Harbin court today. The ... blood collected from an infected couple who sold their blood ... Northeast China. // It was found that 15 people were ... and the other four got infection indirectly from the infected, ...
... Uttar Pradesh Government Railway Police and Junior doctors who ... by Meerut Nauchandi Express lead to injuring medicos and ... police personnel occupying the reserved seats of the medicos. ... state medical colleges for three days ordering enquiry and ...
... Adelaide Supreme Court jury is hearing the case of a HIV ... his accused of having unprotected sex with three of his girlfriend. ... not inform his girlfriends that he has the virus and has ... the three girls with whom he had unprotected sex is now ...
Cached Medicine News:
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... Adapter in conjunction with the Vortex Genie 2 ... Mo Bio Vortex Adapter is an inexpensive alternative ... which offer the same technology. This particular ... one time and will fit any Vortex Genie ...
... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Compact Housing Model V-500 ... to handle most vacuum applications. Applications ... two rotary evaporators Laboratory vacuum source ...
Medicine Products: